Journal
BIOCHEMICAL ENGINEERING JOURNAL
Volume 114, Issue -, Pages 73-81Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bej.2016.06.029
Keywords
Enzymatic membrane reactor; Esterase immobilization; Erythromycin degradation; Ceramic membrane; Wastewater treatment
Funding
- European Union's Seventh Framework Programme for Research, Technological Development and Demonstration [282818]
Ask authors/readers for more resources
Erythromycin is an antibiotic considered as a recalcitrant pollutant because it is currently found in treated wastewaters. In addition, traces of antibiotics are a threatening ecological issue as these compounds are biologically active even at very low concentrations (ng L-1). In this work, we studied enzymatic degradation of this antibiotic in model aqueous solutions containing 20 mg L-1 erythromycin. We used as the biocatalyst an EreB esterase obtained from a genetically modified Escherichia coli W3110 strain carrying the EreB overexpression plasmid. Experiments were carried out with different reactor and biocatalyst configurations (free and immobilized by covalent grafting or adsorption). Free enzymes showed very high activity leading to erythromycin depletion. Experiments with the biocatalyst immobilized by adsorption using an enzymatic membrane reactor showed that even if EreB initially lost part of its activity, it was stabilized and able to continuously degrade erythromycin at a rate of 15.8 mg h(-1) for 100 h. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available